• Medical - Devices
  • Healthcare
Medtronic plc logo
Medtronic plc
MDT · IE · NYSE
81.51
USD
+1.02
(1.25%)
Company Overview

20 ON HATCH, LOWER HATCH STREET,DUBLIN L2 2,01135314381700

CEO

Mr. Geoffrey Straub Martha

Employess

95000

Sector

Healthcare

Industry

Medical - Devices

Website

https://www.medtronic.com

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Next Earnings Date

Nov. 19, 2024

Ex Dividends date

Jul. 12, 2024

Dividend Date

June 28, 2024

YTD Performance

-1.61%

Fiscal Year End

04-29

IPO Date

1973-05-02

Growth Rates
(avg. rate of change) 10 years 5 years 3 years 1 year
Sales/Revenue 6.65% 1.16% 2.43% 3.64%
EPS -0.99% -4.24% 1.11% -2.12%
Equity 9.95% 0.05% -0.79% -2.46%
Cash -0.88% -21.81% -29.04% -16.79%
Return On Capital (ROIC) 5.69% 6.14% 5.94% 5.82%
Debt
year (millions) 2024 2023 2022 2021 2020
Short Term Debt 1,280 20 3,740 11 2,780
Long Term Debt 23,900 24,300 20,400 26,400 22,000
LT Finance Leases 895 64 62 71 50
Shares Outstanding 1,330 1,330 1,340 1,340 1,340
Market Cap 106,000 121,000 140,000 176,000 133,000
Price
Business Segments (Beta)
Geographical Segments (Beta)
News
3 AI-Powered Healthcare Stocks Transforming Medicine
2 months

AI healthcare stocks can potentially revolutionize patient care as we know it. The groundbreaking technology is expected to have a pervasive impact on the investment world, with its most profound anticipated transformations in healthcare.

investorplace.com
Medtronic Stock Moves Above 50-Day SMA: Should You Buy MDT?
2 months

Medtronic's (MDT) stock finally breaking above its 50-day SMA can be a piece of good news for investors, signaling an uptrend.

zacks.com
Medtronic (MDT) Stock Dips While Market Gains: Key Facts
2 months

Medtronic (MDT) closed at $80.32 in the latest trading session, marking a -0.61% move from the prior day.

zacks.com
Federated Hermes, Inc. launches four MDT quantitative active ETFs
2 months

•  New products double the number of Federated Hermes ETFs  PITTSBURGH , July 31, 2024 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in investment management, today announced the launch of four actively managed ETFs that take a quantitative approach to stock selection. The new products offer investors another way to access the disciplined Federated Hermes MDT investment process, crafted and refined for more than 30 years and now available in an ETF structure.

prnewswire.com
My Best Dividend Aristocrats For August 2024
2 months

The ProShares S&P 500 Dividend Aristocrats ETF slumps to end the first half of 2024, posting a loss of 1.40% in June. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 36 months of tracking these strategies, two strategies are outperforming NOBL, while 1 remains relatively close.

seekingalpha.com
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing
2 months

Medtronic (MDT) concluded the recent trading session at $80, signifying a +1.65% move from its prior day's close.

zacks.com
3 AI-in-Healthcare Stocks to Buy for Outsized Returns
2 months

Across industries, companies will need to adopt AI for growth and survival. A PricewaterhouseCoopers indicates that by 2030, AI could contribute up to $15.7 trillion to the global economy.

investorplace.com
3 Blue-Chip Stocks to Buy for the Second Half of 2024
2 months

Blue-chip stocks are known for their stability, but recent investor caution suggests that even these giants aren't immune to scrutiny. Following a rollicking start to the year, the stock market is consolidating.

investorplace.com
Grab These 5 Overlooked Dividend Aristocrats Before Wall Street Catches On
2 months

24/7 Insights The Dividend Aristocrats provide dependable passive income streams.

247wallst.com
Medtronic (MDT) is a Top-Ranked Value Stock: Should You Buy?
2 months

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com
Medtronic (MDT) Stock Sinks As Market Gains: Here's Why
2 months

Medtronic (MDT) closed at $79.30 in the latest trading session, marking a -0.23% move from the prior day.

zacks.com
If You Can Only Buy One Robotics Stock in July, It Better Be One of These 3 Names
2 months

Automation advancements have been incredible, putting the spotlight on the robotics sector as a whole. Indeed, the rise of artificial intelligence has boosted robotics use in manufacturing, healthcare, and e-commerce.

investorplace.com